about
Awareness, knowledge, and interest in interventional radiology among final year medical students in England.Diabetes mellitus and heart failure: a deadly duo.Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure.Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator.Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes.Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart Failure.Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure.[Calcium supplementation in healthy subjects: benefits and risks].Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection FractionPrevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection FractionCoronary subclavian steal syndrome-is there a need for routine assessment for subclavian artery stenosis following coronary bypass surgery?Predicting one‐year mortality in heart failure using the ‘Surprise Question’: a prospective pilot studyVitamin D deficiency is an independent predictor of mortality in patients with chronic heart failureInfluences of clinical experience in the quantification of morphometric sarcopaenia: a cohort studyValidation of two-dimensional vertebral body parameters in estimating patient height in elderly patientsPrescribing diabetes medication for cardiovascular risk reduction in patients admitted with acute coronary syndromes - a survey of cardiologists' attitudes and practiceInfluence of psoas muscle area on mortality following elective abdominal aortic aneurysm repairVolumetric versus single slice measurements of core abdominal muscle for sarcopeniaCorrespondence
P50
Q38773384-E671C668-5CCF-42E4-9A20-8E9DA4906BA7Q42322227-5F5B6A2F-D021-4F6A-B85D-8A028FE69BD3Q47550819-86B47F8A-690F-4F56-AE4B-A79A5C83AA4AQ47768449-9C5CF512-BC3B-4943-BCFA-A70BC62F71A6Q48236335-F3EA94D5-B072-4707-AB8A-A228B285E5F6Q49954439-666C9964-13AA-4315-871E-0930BD3088ACQ52840100-821B06C2-69F9-438C-99E3-EF47B8C6F1ECQ54361731-1BA31E9D-BA53-4181-88E8-7C0FCCFE0F81Q58121759-80F63A53-4A69-4631-9BF1-C5DDE6D59353Q58121829-627FECBA-7865-478C-B153-0A7559D27814Q59334998-DCAADE41-A326-4786-8C46-FAD42E73190CQ61821461-94BBD8F1-2CE0-4847-A453-3047622C54B0Q61842050-D6F324AF-07B1-4193-9CBA-A21E84378363Q61848323-C22BABD9-44B1-4948-AA6B-C7AEF3EC97C5Q90605289-E9329E23-7022-4AE3-9315-5A47F1CAA2ECQ91183789-F36B9D06-EE39-4761-AC15-6090A82EDCB4Q91300699-BD4A9754-B690-4E94-B699-884B15DCBF78Q92626198-77756E31-067E-4EE1-9553-80FF9F780E3EQ95496985-BEF4016B-6DE4-4A05-92B2-00904905B111
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael Drozd
@af
Michael Drozd
@an
Michael Drozd
@ast
Michael Drozd
@ay
Michael Drozd
@az
Michael Drozd
@br
Michael Drozd
@ca
Michael Drozd
@ce
Michael Drozd
@ceb
Michael Drozd
@co
type
label
Michael Drozd
@af
Michael Drozd
@an
Michael Drozd
@ast
Michael Drozd
@ay
Michael Drozd
@az
Michael Drozd
@br
Michael Drozd
@ca
Michael Drozd
@ce
Michael Drozd
@ceb
Michael Drozd
@co
prefLabel
Michael Drozd
@af
Michael Drozd
@an
Michael Drozd
@ast
Michael Drozd
@ay
Michael Drozd
@az
Michael Drozd
@br
Michael Drozd
@ca
Michael Drozd
@ce
Michael Drozd
@ceb
Michael Drozd
@co
P6366
P106
P1153
56576092900
P21
P31
P496
0000-0003-0255-4624
P6178
01002342106.56
P6366
2102768623